Direct oral anticoagulants in patients with bioprosthetic heart valves

Intern Emerg Med. 2023 Aug;18(5):1269-1272. doi: 10.1007/s11739-023-03288-7. Epub 2023 May 27.

Author

Giulia Renda^{1

2}

Affiliations

¹ Institute of Cardiology, Department of Neuroscience, Imaging and Clinical Sciences, G. d'Annunzio University Chieti-Pescara, Via L. Polacchi 11, 66100, Chieti, Italy. giulia.renda@unich.it.
² Cardiology Unit - SS. Annunziata Hospital, Via Dei Vestini 31, 66100, Chieti, Italy. giulia.renda@unich.it.

PMID: 37243834
DOI: 10.1007/s11739-023-03288-7

No abstract available

Keywords: Atrial fibrillation; Bioprosthetic heart valves; Direct oral anticoagulant; Valvular heart disease.

Publication types

Comment

MeSH terms

Administration, Oral
Anticoagulants / therapeutic use
Atrial Fibrillation* / drug therapy
Heart Valves
Humans
Stroke*

Substances

Anticoagulants